BIOXCEL THERAPEUT DL-,001 Forum: Community User: Adler.

Schreib das Geld ab und suche etwas gescheites.

Leider

Klingt nicht wirklich ermutigend.

BioXcel Therapeutics, Inc. (BTAI) is a pioneering biopharmaceutical company that is leveraging the power of AI to develop transformative medicines in neuroscience and immuno-oncology. The company's lead product, IGALMI TM, has been approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder, and BTAI is working to expand its commercial reach and pipeline. However, BTAI faces significant challenges, including its limited operating history, ongoing net losses, and substantial doubt about its ability to continue as a going concern. The company's reliance on third-party manufacturers and its relationship with BioXcel LLC also introduce additional risks. As BTAI navigates these obstacles and continues to advance its clinical programs, investors should closely monitor the company's progress, financial performance, and any updates regarding the development and commercialization of its product candidates. The company's ability to effectively execute its strategic reprioritization and secure additional funding will be critical to its long-term success.

In dem Punkt gebe ich ihm recht . Habe drei mal 💩 ReSplit erlebt und , wie der Kollege schon sagt, die 💩 shortseller haben dann wieder mehr Fleisch am Knochen. Ich hasse dieses Drec.kspa.ck. Hoffen wir mal , dass es ohne geht. Zudem wir ein Buy- Rating bekommen haben.

Nachdem RS gibt es eine Party für die Shortseller die euch das restliche Geld aus dem Portmonee nehmen werden. Hierzu gibt es genug Beispiele.

Also kennst du auch keine.

Noch ist rs nicht da

Nenne mir doch eine Aktie, die nach einem RS besser da stand als vorher?